TWST Twist Bioscience Corporation | US90184D1000
Financials
Trends
Details
| Breakdown | 30.09.2027 | 30.09.2026 | Change % |
|---|---|---|---|
| Total Revenue | 519.961.400 | 444.686.100 | 16.93% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -0,85 | -0,77 | 10.39% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 4 | 2 | 100.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |